SCHEMBL21901803

SCHEMBL21901803

Cc1ccc(-c2cnn(C)c2)c(C(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 1/20 0.49
▸ BTK Q06187 1/20 0.44
▸ IRAK1 P51617 2/20 0.41
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ BRD4 O60885 1/20 0.40
▸ ALOX5AP P20292 1/20 0.39
▸ FEN1 P39748 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ ACLY P53396 1/20 0.39
▸ SMARCA2 P51531 1/20 0.38
▸ SMARCA4 P51532 1/20 0.38
▸ AURKA O14965 1/20 0.38
▸ AURKB Q96GD4 1/20 0.38
▸ INCENP Q9NQS7 1/20 0.38
▸ TPX2 Q9ULW0 1/20 0.38
▸ PFKFB3 Q16875 1/20 0.37
▸ AAK1 Q2M2I8 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.37
▸ AXL P30530 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17794669 0.86 LRRK2 (0.48) LRRK2BTKBRD4ALOX5APFEN1
SCHEMBL26505596 0.83 GPR55 (0.46) LRRK2IRAK1IRAK4BRD4ALOX5AP
SCHEMBL17661854 0.83 FGFR3 (0.48) LRRK2IRAK1IRAK4BRD4ALOX5AP
SCHEMBL11962892 0.80 LRRK2 (0.54) LRRK2BTKIRAK4BRD4ALOX5AP
SCHEMBL10094326 0.79 BRD4 (0.50) BTKIRAK1IRAK4BRD4ALOX5AP
SCHEMBL17795258 0.78 LRRK2 (0.51) LRRK2BTKBRD4ALOX5APFEN1
SCHEMBL17794671 0.78 LRRK2 (0.51) LRRK2BTKBRD4PIM1SMARCA2
SCHEMBL17809683 0.77 LRRK2 (0.54) LRRK2BTKBRD4PIM1ACLY
Ammonia Solution, Strong SCHEMBL28956665 0.76 LRRK2 (0.50) LRRK2BTKBRD4ALOX5APFEN1
SCHEMBL17806620 0.75 ALOX5AP (0.41) LRRK2BTKIRAK1IRAK4BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328851-B1 FACTOR XIA MACROCYCLIC INHIBITORS BEARING ALKYL OR CYCLOALKYL P2' MOIETIES BRISTOL MYERS SQUIBB CO (US) 2020-04-22 — — EP disclosed
Send feedback